Jacinto Convit

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Jacinto Convit García (born September 11, 1913 in Caracas[1]) is a Venezuelan Medic and Scientist.[1] In 1987, he received a Prince of Asturias Award in the Scientific and Technical Research category.[1]

In 1988, he was nominated for the Nobel Prize in Medicine, for developing a vaccine to fight leprosy, by combining a tuberculosis (TB) vaccines with Mycobacterium Leprae.

[edit] Cancer vaccine

On June 7th 2010, a Venezuelan newspaper announced the successful development by Dr. Jacinto Convit of a new Cancer vaccine intended to fight colon, stomach and breast cancer.[2]

On June 2010 the "Instituto de Biomedicina" published a note clarifying that they have been working for the last 3 years on a vaccine against cancer and it's still in development. During this time they have been evaluating a small group of 23 patients, mostly breast cancer and a few of colon, stomach and brain cancers. They have been giving patients an experimental model of immunotherapy against cancer, which have had encouraging results. They clarify that is a therapeutic and not prophylactic vaccine. [3]

This vaccine is based on the idea that cancerous cells appear and propagate because the body doesn't detect them. A sample of the tumour mixed with formalin and BCG marks the malignous cells so the immune system reacts and attacks the cancer.

This experimental treatment has a big advantage over the use of traditional quimiotherapy: It has very few side effects. BCG has been used against tuberculosis for a long time on millions of people with no consequences.[4]

[edit] References

[edit] External links

  • [1] Blog about Jacinto Convit's work (in Spanish)
  • document Immunotherapy autovaccine for cancer treatment (in Spanish)


Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages